Pathogenic t cells in guillain barre syndrome
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2110919
- Recipient
-
University Of North Carolina At Chapel Hill UEI D3LHU66KBLD5
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $1,200,470
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Chapel Hill, NC 27599, USA
Award details come from USAspending.gov.
About this award
The University of North Carolina at Chapel Hill was awarded a $1,200,470 project grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research into pathogenic T cells in Guillain-Barré syndrome from September 30, 2021 through September 29, 2025. As part of the Military Medical Research and Development program's goals of transforming military and public health through innovative medical research and investigating battlefield medical solutions, this project aims to advance understanding of the autoimmune response behind Guillain-Barré syndrome. The research will be conducted at the University of North Carolina at Chapel Hill's Office of Sponsored Research in Chapel Hill, North Carolina.
Quick answers
Who received award W81XWH2110919?
W81XWH2110919 was awarded to University Of North Carolina At Chapel Hill by Medical Command (Department of the Army) on September 30, 2021.
How much is award W81XWH2110919 worth?
$1,200,470 has been obligated on W81XWH2110919.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award